95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.50%
Negative revenue growth while FSM stands at 12.15%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.30%
Negative gross profit growth while FSM is at 9.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
-5.62%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-16.06%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-10.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-11.11%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.34%
Share reduction more than 1.5x FSM's 2.68%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.70%
Slight or no buyback while FSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-2.65%
Negative OCF growth while FSM is at 180.79%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-2.65%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
141.24%
10Y CAGR of 141.24% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
124.47%
5Y CAGR of 124.47% while FSM is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
40.43%
Below 50% of FSM's 453.27%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-7.79%
Negative 3Y OCF/share CAGR while FSM stands at 453.27%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
622.91%
Positive 5Y CAGR while FSM is negative. John Neff might view this as a strong mid-term relative advantage.
229.95%
Positive short-term CAGR while FSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
874.54%
10Y equity/share CAGR 1.25-1.5x FSM's 623.18%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
1188.92%
5Y equity/share CAGR above 1.5x FSM's 623.18%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-88.33%
Negative 3Y equity/share growth while FSM is at 623.18%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-13.81%
Firm’s AR is declining while FSM shows 0.55%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
60.34%
Asset growth above 1.5x FSM's 20.30%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.70%
Under 50% of FSM's 17.65%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.06%
We cut SG&A while FSM invests at 277.13%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.